Tricuspid regurgitation and long-term clinical outcomes

Ehud Chorin, Zach Rozenbaum, Yan Topilsky, +5

European Heart Journal - Cardiovascular Imaging

Impact of Right Ventricular Dysfunction and Tricuspid Regurgitation on Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement

Lorin Arie Schwartz, Zach Rozenbaum, Ehab Ghantous, +10

Journal of the American Society of Echocardiography

Right Ventricular DysfunctionHeart FailureTricuspid RegurgitationCardiovascular DiseaseValve Disease +7

CHA2DS2-VASc score and clinical outcomes of patients with acute coronary syndrome

Zach Rozenbaum, Avishay Elis, Mony Shuvy, +6

European Journal of Internal Medicine

Percutaneous Coronary InterventionCardiovascular DiseaseAcute Coronary SyndromeClinical OutcomesAcute Myocardial Infarction +6

Efficacy and safety of new-generation transcatheter aortic valves: insights from the Israeli transcatheter aortic valve replacement registry

Ariel Finkelstein, Arie Steinvil, Zach Rozenbaum, +10

Clinical Research in Cardiology

Patient SafetyVascular SurgeryValve DiseaseSurgeryValvular Heart Disease +4

Association of body mass index and diastolic function in metabolically healthy obese with preserved ejection fraction

Zach Rozenbaum, Yan Topilsky, Shafik Khoury, +2

International Journal of Cardiology

ObesityNutritionMetabolic SyndromeBody CompositionBody Mass Index +9

Left Atrial Strain changes in patients with breast cancer during anthracycline therapy

Michal Laufer‐Perl, Orly Arias, Svetlana Sirota Dorfman, +8

International Journal of Cardiology

Anthracycline TherapyBreast OncologyMedicinePathologyBreast Cancer +4

The association of reduced global longitudinal strain with cancer therapy-related cardiac dysfunction among patients receiving cancer therapy

Michal Laufer‐Perl, Joshua H. Arnold, Liat Mor, +7

Clinical Research in Cardiology

Cancer TherapyCardiovascular ToxicityCardiomyopathyHeart FailureCardiovascular Disease +9

Long-term renal outcomes and mortality following renal injury among myocardial infarction patients treated by primary percutaneous intervention

Natalia Kofman, Gilad Margolis, Amir Gal‐Oz, +4

Coronary Artery Disease

Re-introducing immunotherapy in patients surviving immune checkpoint inhibitors-mediated myocarditis

Shira Peleg Hasson, Benjamin Salwen, Ayelet Sivan, +10

Clinical Research in Cardiology

Tumor ImmunologyAutoimmune DiseaseImmunosuppressive TherapyImmunologyImmune Checkpoint Inhibitor +5

Relation of lowering door-to-balloon time and mortality in ST segment elevation myocardial infarction patients undergoing percutaneous coronary intervention

David Zahler, Keren Lee-Rozenfeld, Dor Ravid, +4

Clinical Research in Cardiology

Percutaneous Coronary InterventionCardiovascular DiseasePatient SafetyDoor-to-balloon TimeOutcomes Research +7